Pricing Log in Create free account

Genenta Science S.p.A. Unsponsored ADR (GNTA) vs NextCure, Inc. (NXTC)

Genenta Science S.p.A. Unsponsored ADR and NextCure, Inc. are both Biotechnology companies. Genenta Science S.p.A. Unsponsored ADR and NextCure, Inc. are of similar size ($32.3M and $31.5M). Across the 7 metrics below, Genenta Science S.p.A. Unsponsored ADR leads on 5 and NextCure, Inc. on 2.

Valuation

Metric GNTA NXTC Biotechnology median
P/E — n/m 8.50
P/S n/m 1.21 9.71
P/B n/m 2.73 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.57 9.21
Earnings yield — (139.42%) (33.15%)
Free cash flow yield 0.00% (113.06%) (25.50%)

Profitability

Metric GNTA NXTC Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (195.22%) (56.36%)
Return on assets 0.00% (121.60%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNTA NXTC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 30.19% 17.75% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNTA NXTC Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 14.16 3.47 4.72
Net debt to EBITDA 3.12 0.75 0.96

Dividend

Metric GNTA NXTC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNTA NXTC Biotechnology median
Market cap 32.28m 31.49m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack